辉瑞首席执行官:我们对Metsera的收购报价已考虑到GLP-1类药物价格可能会开始下降。
辉瑞首席执行官:我们对Metsera的收购报价已考虑到GLP-1类药物价格可能会开始下降。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.